Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
International Journal of Biological Sciences|July 27, 2023
Rapamycin and Low-dose IL-2 Mediate an Immunosuppressive Microenvironment to Inhibit Benign Prostatic HyperplasiaTianyu Cao, Feng Xie, Youwei Shi, et al.The Journal of Sexual Medicine|August 23, 2022
The Efficacy and Safety of Thrice vs Twice per Week Low-Intensity Pulsed Ultrasound Therapy for Erectile Dysfunction: A Randomized Clinical TrialHuirong Chen, Zheng Li, Xianchen Li, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 2, 2025
Disrupting Lipid Raft Microdomains to Block Polyploid Giant Cancer Cell Budding and Enhance Radiotherapy ResponseZheng Deng, Haoran Sun, Jin Cheng, et al.Molecular Cell|July 21, 2023
A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signalingJianong Zhang, Jiangbo Wei, Rui Sun, et al.Med (New York, N.Y.)|October 17, 2024
Correlation of PSA and survival in metastatic hormone-sensitive prostate cancer treated with rezvilutamide plus ADT in the CHART trialXiaojie Bian, Weijie Gu, Xuepei Zhang, et al.Asian Pacific Journal of Cancer Prevention : APJCP|May 5, 2007
The 5th Conference on Asian Trends in Prostate Cancer Hormone TherapyHideyuki Akaza, Malcolm A Moore, Shu-Jen Chang, et al.BJU International|February 26, 2017
Prevalence of kidney stones in China: an ultrasonography based cross-sectional studyGuohua Zeng, Zanlin Mai, Shujie Xia, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 31, 2004
The 3rd Conference on Asian Trends in Prostate Cancer Hormone TherapyHideyuki Akaza, Seiji Naito, Shu-Jen Chang, et al.Frontiers in Pharmacology|March 7, 2022
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled TrialLimin Liao, Qinggang Liu, Huiling Cong, et al.Asian Journal of Urology|February 19, 2019
Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese populationLiqun Zhou, Kaiwei Yang, Xuesong Li, et al.Pageof 11